Clinical Trials Browser

Phase 2 × Osteosarcoma × Eflornithine × Clear all

NCT07321912 2026-01-08

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Phase 2 Not yet recruiting

Sarcoma, Ewing, Osteosarcoma